Hubei Minkang Pharmaceutical Ltd. — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$14.7M

Net Income/Loss (FY2013)

$127.3K

Total Assets (FY2013)

$21.6M

Total Equity (FY2013)

$11.4M

Cash Flows from Operating Activities (FY2013)

$913.1K

Source: Hubei Minkang Pharmaceutical Ltd. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.